Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 663-672

  Flood, Dorothy G ^a   Reaume, Andrew G ^a   Gruner, John A ^a   Hoffman, Eric K ^a   Hirsch, James D ^a   Lin, Yin Guo ^a   Dorfman, Karen S ^a   Scott, Richard W ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; DEGENERATIVE DISEASE; HINDLIMB; MOTONEURON; MUSCLE DENERVATION; NERVE CONDUCTION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032776668     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65162-0     Document Type: Article

References (44)

1. Gutteridge JMC: Free radicals in disease processes: a compilation of cause and consequence. Free Rad Res Commun 1993, 19:141-158
2. Good PF, Werner P, Hsu A, Olanow CW, Perl DP: Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996, 149:21-28
3. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM: RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691
4. Yankner BA: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996, 16:921-932
5. Browne SE, Bowling AC, MacGarvey U, Beal MF: Oxidative DNA damage, and impaired mitochondrial metabolism in Huntington's disease. Soc Neurosci Abstr 1995, 21:489
6. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AHV, Jenner P, Marsden CD: Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 1994, 35:38-44
7. Yoritaka A, Hatton N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y: Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996, 93:2696-2701
8. Shaw PJ, Ince PG, Falkous G, Mantle D: Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995, 38:691-695
9. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H-X, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B: Van den Bergh R, Hung W-Y, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH Jr: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62
10. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H-X, Chen W, Zhai P, Sufit RL, Siddique T: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264: 1772-1775
11. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW: Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995, 92:689-693
12. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL: An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14:1105-1116
13. Wong PC, Borchelt DR: Motor neuron disease caused by mutations in superoxide dismutase 1. Curr Opin Neurol 1995, 8:294-301
14. Bruijn LI, Becher MW, Lee MK, Andersor KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW: ALS-linked SOD1 mutant G85R mediates damage to astrocytes, and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338
15. Bruijn LI, Beal MF, Becher MW, Schulz JB, Wong PC, Price DL, Cleveland DW: Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 1997, 94:7606-7611
16. 2. Proc Natl Acad Sci USA 1998, 95:6675-6680
17. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW: Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998, 281:1851-1854
18. Fridovich I: Superoxide dismutases. Adv Enzymol Relat Areas Molec Biol 1986, 58:61-97
19. Beyer W, Imlay J, Fridovich I: Superoxide dismutases. Prog Nucl Acid Res Molec Biol 1991, 40:221-253
20. Bilinski T, Krawiec Z, Liczmanski A, Litwinska J: Is hydroxyl radical generated by the Fenton reaction in vivo? Biochem Biophys Res Commun 1985, 130:533-539
21. van Loon AP, Pesold-Hurt B, Schatz G: A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc Natl Acad Sci USA 1986, 83:3820-3824
22. Gralla EB, Kosman DJ: Molecular genetics of superoxide dismutases in yeasts and related fungi. Adv Genet 1992, 30:251-319
23. Phillips JP, Campbell SD, Michaud D, Charbonneau M, Hilliker AJ: Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci USA 1989, 86:2761-2765
24. Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995, 11:376-381
25. Lebovitz RM, Zhang H, Vogel H, Cartwright J Jr, Dionne L, Lu N, Huang S, Matzuk MM: Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice: Proc Natl Acad Sci USA 1996, 93:9782-9787
26. Carlsson LM, Jonsson J, Edlund T, Marklund SL: Mice lacking extra-cellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995, 92:6264-6268
27. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD: Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996, 13:43-47
28. Kondo T, Reaume AG, Huang T-T, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH: Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 1997, 17:4180-4189
29. Howland DS, Savage MJ, Huntress FA, Wallace RE, Schwartz DA, Loh T, Melloni RH Jr, DeGennaro LJ, Greenberg BD, Siman R, Swanson ME, Scott RW: Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging 1995, 16:685-699
30. Bewley GC: cDNA and deduced amino acid sequence of murine Cu-Zn superoxide dismutase. Nucleic Acids Res 1988, 16:2728
31. Hoesche C, Sauerwald A, Veh RW, Krippl B, Kilimann MW: The 5′-flanking region of the rat synapsin I gene directs neuron-specific, and developmentally regulated reporter gene expression in transgenic mice: J Biol Chem 1993, 268:26494-26502
32. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994, 634:7-12
33. Sharma AK, Thomas PK: Peripheral nerve structure and function in experimental diabetes. J Neurol Sci 1974, 23:1-15
34. Dubowitz V: Muscle Biopsy, A Practical Approach, 2nd Edition, London, Baillière Tindall, 1985, 720 pp
35. Gurney ME, Yamamoto H, Kwon Y: Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and basic fibroblast growth factor. J Neurosci 1992, 12:3241-3247
36. Karnes J, Robb R, O'Brien PC, Lambert EH, Dyck PJ: Computerized image recognition for morphometry of nerve attribute of shape of sampled transverse sections of myelinated fibers which best estimates their average diameter. J Neurol Sci 1977, 34:43-51
37. Hoffman EK, Wilcox HM, Scott RW, Siman R: Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. J Neurol Sci 1996, 139:15-20
38. Carter RB: Differentiating analgesic and non-analgesic drug activities on rat hot plate: effect of behavioral endpoint. Pain 1991, 47:211-220
39. Bird SJ: Pure motor neuropathy. Curr Opin Neurol Neurosurg 1990, 3:704-707
40. Dyck PJ, Chance P, Lebo R, Carney JA: Hereditary motor and sensory neuropathies. Peripheral Neuropathy. Volume 2, 3rd Edition. Edited by PJ Dyck, PK Thomas, JW Griffin, PA Low, JF Poduslo. Philadelphia, WB Saunders Co, 1993, pp 1094-1136
41. Brinley FJ Jr: Excitation and conduction in nerve fibers. Medical Physiology, Volume 1, 13th Edition. Edited by VB Mountcastle. St. Louis, C.V. Mosby Co, 1974, pp 34-76
42. Bergeron K, Petrunka C, Weyer L: Copper/zinc superoxide dismutase expression in the human central nervous system: correlation with selective neuronal vulnerability. Am J Pathol 1996, 148:273-279
43. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW: Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 1995, 92:954-958
44. McHanwell S, Biscoe TJ: The sizes of motoneurons supplying hindlimb muscles in the mouse. Proc R Soc Lond B 1981, 213:210-216